All Stories

  1. Type II Toxin-Antitoxin Systems: Evolution and Revolutions

    Article • Journal of Bacteriology, January 2020, ASM Journals

    Dr Frédéric Goormaghtigh

  2. Antibiotic chemotherapy against heterogeneous pathogen populations in complex host tissues

    Article • F1000Research, October 2019, Faculty of 1000, Ltd.

    Dr Frédéric Goormaghtigh

  3. Single-cell imaging and characterization of Escherichia coli persister cells to ofloxacin in exponential cultures

    Article • Science Advances, June 2019, American Association for the Advancement of Science

    Dr Frédéric Goormaghtigh

  4. Growth-dependent recombinant product formation kinetics can be reproduced through engineering of glucose transport and is prone to phenotypic heterogeneity

    Article • Microbial Cell Factories, February 2019, Springer Science + Business Media

    Dr Frédéric Goormaghtigh

  5. Toxin-Antitoxin Systems and Persistence

    Article • January 2019, Springer Science + Business Media

    Dr Frédéric Goormaghtigh

  6. Reply to Holden and Errington, “Type II Toxin-Antitoxin Systems and Persister Cells”

    Article • mBio, September 2018, ASM Journals

    Niilo Kaldalu, Dr Frédéric Goormaghtigh

  7. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells

    Article • mBio, June 2018, ASM Journals

    Dr Andreas Sjodin, Niilo Kaldalu, Dr Frédéric Goormaghtigh

  8. Optimized Method for Measuring Persistence in Escherichia coli with Improved Reproducibility

    Article • January 2016, Springer Science + Business Media

    Dr Frédéric Goormaghtigh